Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Forni

Showing results (71-80 of 97) with videos related to

Pageof 10
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 1996
Synchronous multifocal osteosarcoma: results in twelve patients treated with neoadjuvant chemotherapy and simultaneous resection of all involved bonesG Bacci, P Picci, S Ferrari, et al.
Minerva Pediatrica|November 1, 1995
[Neoadjuvant treatment of Ewing's sarcoma: results obtained in 122 patients treated with a 6-drug chemotherapeutic protocol (vincristine, adriamycin, cyclophosphamide, dactinomycin, ifosfamide and etoposide)]G Bacci, S Ferrari, P Rosito, et al.
Cancer|January 15, 1997
Osteogenic sarcoma of the extremity with detectable lung metastases at presentation. Results of treatment of 23 patients with chemotherapy followed by simultaneous resection of primary and metastatic lesionsG Bacci, M Mercuri, A Briccoli, et al.
Minerva Chirurgica|April 1, 1997
[The type of local treatment conditions the prognosis in patients with nonmetastatic Ewing's sarcoma of the extremities treated with adjuvant chemotherapy]G Bacci, S Ferrari, P Rosito, et al.
Plant Physiology and Biochemistry : PPB|November 19, 2013
Characterization of the response of in vitro cultured Myrtus communis L. plants to high concentrations of NaClP Di Cori, S Lucioli, A Frattarelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2000
Prognostic factors in nonmetastatic Ewing's sarcoma of bone treated with adjuvant chemotherapy: analysis of 359 patients at the Istituto Ortopedico RizzoliG Bacci, S Ferrari, F Bertoni, et al.
Acta Oncologica (Stockholm, Sweden)|February 7, 2001
Neoadjuvant chemotherapy for Ewing's sarcoma of bone in patients older than thirty-nine yearsG Bacci, S Ferrari, A Comandone, et al.
Cancer|March 20, 1998
Neoadjuvant chemotherapy for Ewing's sarcoma of bone: no benefit observed after adding ifosfamide and etoposide to vincristine, actinomycin, cyclophosphamide, and doxorubicin in the maintenance phase--results of two sequential studiesG Bacci, P Picci, S Ferrari, et al.
Acta Orthopaedica Scandinavica|May 25, 2001
Telangiectatic osteosarcoma of the extremity: neoadjuvant chemotherapy in 24 casesG Bacci, S Ferrari, P Ruggieri, et al.
The Journal of Bone and Joint Surgery. British Volume|February 12, 2002
Osteosarcoma of the limb. Amputation or limb salvage in patients treated by neoadjuvant chemotherapyG Bacci, S Ferrari, S Lari, et al.
Pageof 10

Showing results (71-80 of 97) with videos related to

Sort By:
Pageof 10
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 1996
Synchronous multifocal osteosarcoma: results in twelve patients treated with neoadjuvant chemotherapy and simultaneous resection of all involved bonesG Bacci, P Picci, S Ferrari, et al.
Minerva Pediatrica|November 1, 1995
[Neoadjuvant treatment of Ewing's sarcoma: results obtained in 122 patients treated with a 6-drug chemotherapeutic protocol (vincristine, adriamycin, cyclophosphamide, dactinomycin, ifosfamide and etoposide)]G Bacci, S Ferrari, P Rosito, et al.
Cancer|January 15, 1997
Osteogenic sarcoma of the extremity with detectable lung metastases at presentation. Results of treatment of 23 patients with chemotherapy followed by simultaneous resection of primary and metastatic lesionsG Bacci, M Mercuri, A Briccoli, et al.
Minerva Chirurgica|April 1, 1997
[The type of local treatment conditions the prognosis in patients with nonmetastatic Ewing's sarcoma of the extremities treated with adjuvant chemotherapy]G Bacci, S Ferrari, P Rosito, et al.
Plant Physiology and Biochemistry : PPB|November 19, 2013
Characterization of the response of in vitro cultured Myrtus communis L. plants to high concentrations of NaClP Di Cori, S Lucioli, A Frattarelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2000
Prognostic factors in nonmetastatic Ewing's sarcoma of bone treated with adjuvant chemotherapy: analysis of 359 patients at the Istituto Ortopedico RizzoliG Bacci, S Ferrari, F Bertoni, et al.
Acta Oncologica (Stockholm, Sweden)|February 7, 2001
Neoadjuvant chemotherapy for Ewing's sarcoma of bone in patients older than thirty-nine yearsG Bacci, S Ferrari, A Comandone, et al.
Cancer|March 20, 1998
Neoadjuvant chemotherapy for Ewing's sarcoma of bone: no benefit observed after adding ifosfamide and etoposide to vincristine, actinomycin, cyclophosphamide, and doxorubicin in the maintenance phase--results of two sequential studiesG Bacci, P Picci, S Ferrari, et al.
Acta Orthopaedica Scandinavica|May 25, 2001
Telangiectatic osteosarcoma of the extremity: neoadjuvant chemotherapy in 24 casesG Bacci, S Ferrari, P Ruggieri, et al.
The Journal of Bone and Joint Surgery. British Volume|February 12, 2002
Osteosarcoma of the limb. Amputation or limb salvage in patients treated by neoadjuvant chemotherapyG Bacci, S Ferrari, S Lari, et al.
Pageof 10